• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ebola virus - Articles and news items

PREVAIL IV – a trial to investigate if GS-5734 eliminates Ebola virus from semen

Industry news / 5 July 2016 / Victoria White, Digital Content Producer

The six-month study will enrol 60 to 120 Ebola survivors whose semen has evidence of Ebola virus RNA prior to their enrolment…

Positive Phase I results for preventive Ebola vaccine regimen

Industry news / 20 April 2016 / Victoria White, Digital Content Producer

Data from a Phase I study of a preventive Ebola vaccine regimen suggest that the regimen was well-tolerated by healthy volunteers and immunogenic…

Inovio’s Ebola vaccine generates robust immune responses in humans

Industry news / 30 March 2016 / Victoria White

Inovio’s Ebola vaccine, INO-4212, was safe, tolerable, and generated strong T cell and antibody responses in its Phase I study of 75 healthy subjects…

Gilead’s GS-5734 given to UK Ebola patient

Industry news / 22 October 2015 / Victoria White

GS-5734 was discovered as part of Gilead’s programme to screen compounds in its libraries for activity against a range of potential emerging viruses, including Ebola…

BARDA funding awarded to accelerate Ebola vaccine programme

Industry news / 15 September 2015 / Victoria White

Crucell Holland has been awarded $28.5 million from BARDA to help accelerate the development of its investigational Ebola prime-boost vaccine regimen…

Sierra Leone down to last chain of Ebola transmission

Industry news / 17 August 2015 / Victoria White

An epidemiological week has now passed with no new Ebola cases in Sierra Leone for the first time since the beginning of the outbreak…

Ebola vaccine found to have 100% efficacy in a Phase 3 trial

Industry news / 31 July 2015 / Victoria White

Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial…

Novavax announces positive top-line data from Phase 1 Ebola vaccine trial

Industry news / 22 July 2015 / Victoria White

Novavax has announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein recombinant nanoparticle vaccine candidate…

Tekmira to change company name; suspends development of ebola drug

Industry news / 21 July 2015 / Victoria White

Tekmira Pharmaceuticals Corporation has announced plans to change its corporate name to Arbutus Biopharma Corporation, to be effective by 3 August 2015…

Oxford Vaccine Group initiates Phase 2 study of Ebola prime-boost vaccine regimen combining MVA-BN-Filo and Ad26.ZEBOV

Industry news / 15 July 2015 / Victoria White

Oxford Vaccine Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines MVA-BN-Filo with Ad26.ZEBOV…

Enrolment stops for Phase II TKM-Ebola-Guinea trial

Industry news / 23 June 2015 / Victoria White

Tekmira has announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.

EIB supports Bavarian Nordic’s development of Ebola and cancer vaccines

Industry news / 13 May 2015 / Victoria White

EIB has reaffirmed its commitment to respond to the Ebola pandemic by providing a EUR 50m loan to Bavarian Nordic for accelerated development of a vaccine…